ATE394675T1 - Verfahren zum nachweis von brustkrebs - Google Patents

Verfahren zum nachweis von brustkrebs

Info

Publication number
ATE394675T1
ATE394675T1 AT03769086T AT03769086T ATE394675T1 AT E394675 T1 ATE394675 T1 AT E394675T1 AT 03769086 T AT03769086 T AT 03769086T AT 03769086 T AT03769086 T AT 03769086T AT E394675 T1 ATE394675 T1 AT E394675T1
Authority
AT
Austria
Prior art keywords
breast
breast cancer
fluids
detected
reagent
Prior art date
Application number
AT03769086T
Other languages
English (en)
Inventor
Jiri Krepinsky
Rudolf Furrer
Ka Yeung
Original Assignee
Sentina Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentina Biotechnology Inc filed Critical Sentina Biotechnology Inc
Application granted granted Critical
Publication of ATE394675T1 publication Critical patent/ATE394675T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
AT03769086T 2002-10-11 2003-10-09 Verfahren zum nachweis von brustkrebs ATE394675T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41791802P 2002-10-11 2002-10-11

Publications (1)

Publication Number Publication Date
ATE394675T1 true ATE394675T1 (de) 2008-05-15

Family

ID=32094121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769086T ATE394675T1 (de) 2002-10-11 2003-10-09 Verfahren zum nachweis von brustkrebs

Country Status (8)

Country Link
US (4) US20060246415A1 (de)
EP (1) EP1554584B1 (de)
JP (1) JP2006502390A (de)
AT (1) ATE394675T1 (de)
AU (1) AU2003278005A1 (de)
CA (1) CA2501330A1 (de)
DE (1) DE60320821D1 (de)
WO (1) WO2004034059A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020117169A1 (en) 2001-02-27 2002-08-29 Kurz Daniel R. Cover and applicator for a portion of a mammalian body
WO2004034059A1 (en) 2002-10-11 2004-04-22 Sentina Biotechnology Incorporated Methods for detection of breast cancer
CN101305100A (zh) * 2005-09-19 2008-11-12 普雷姆德股份有限公司 液相半乳糖氧化酶希夫测定法
US20100256464A1 (en) * 2007-05-14 2010-10-07 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof
WO2010099137A2 (en) * 2009-02-26 2010-09-02 Osi Pharmaceuticals, Inc. In situ methods for monitoring the emt status of tumor cells in vivo
US11857369B1 (en) 2012-01-16 2024-01-02 Vall A. Iliev System and method for generation and display of ultrasound imaging data
WO2014199228A2 (en) * 2013-03-15 2014-12-18 Newcastle Innovation Ltd Detection of brca carriers in breast tissue

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US65978A (en) * 1867-06-18 wilder
FR792353A (fr) 1935-07-11 1935-12-30 Gaine de protection des mamelons pendant l'allaitement
US3229691A (en) * 1963-07-10 1966-01-18 Johnson & Johnson Flexible absorbent sheet
US3786801A (en) * 1969-02-24 1974-01-22 Diagnostic Inc Method and apparatus for aiding in the detection of breast cancer
US3782377A (en) * 1971-09-07 1974-01-01 Illinois Tool Works Sterile plastic shield
US3867517A (en) * 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
US3840012A (en) * 1973-10-17 1974-10-08 R Rushton Milk collector and shield for nursing women
US4195639A (en) * 1976-03-05 1980-04-01 Lee Denis C External breast prosthesis
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
DE2901218A1 (de) * 1979-01-13 1980-07-17 Byk Gulden Lomberg Chem Fab Ung von theophyllin
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4333471A (en) * 1981-01-19 1982-06-08 Tokiwa Chemical Industries, Limited Nipple cover
JPS6071702A (ja) * 1983-09-28 1985-04-23 日交化工材株式会社 人体貼着用シ−ト
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
GB2150028A (en) 1983-11-09 1985-06-26 Michael William Nolan Wound dressings
US4667666A (en) * 1986-04-18 1987-05-26 Alice Fryslie Protective bandaging device
US4870977A (en) * 1987-03-20 1989-10-03 Coopervision, Inc. Surgical protector for raised wounds
US4754750A (en) * 1987-03-20 1988-07-05 Coopervision, Inc. Areola/nipple surgical wound protector
US5348860A (en) * 1988-08-04 1994-09-20 Shamsuddin Abulkalam M Screening test and kit for cancerous and precancerous conditions
US4917112A (en) * 1988-08-22 1990-04-17 Kalt Medical Corp. Universal bandage with transparent dressing
DE3907007A1 (de) 1989-03-04 1990-09-13 Joachim Dr Med Kell Wundverband
US5032103A (en) * 1990-02-16 1991-07-16 Isg/Ag Breast shield
US5230350A (en) * 1991-05-29 1993-07-27 Tabex Industries, Inc. Moisture barrier for indwelling catheters and the like
EP0609236B1 (de) * 1991-10-23 2002-05-02 L.L.C. Patent Holdings Wundverbandsystem
AU5575294A (en) * 1992-12-07 1994-07-04 Hisamitsu Pharmaceutical Co., Inc. Plaster for testing and method of testing
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer
US6093160A (en) * 1994-11-21 2000-07-25 Augustine Medical, Inc. Flexible non-contact wound treatment device
US6005159A (en) * 1995-02-17 1999-12-21 Alan J. Ackerman Protective covering for body lesions
US5627034A (en) * 1995-12-05 1997-05-06 Wisconsin Alumni Research Foundation Assay for carcinoma proliferative status by measuring NGAL expression level
US5740550A (en) * 1996-03-15 1998-04-21 Yavitz; Edward Q. Membrane shield for eyes
US5743272A (en) * 1996-04-10 1998-04-28 Kocher, Jr.; Robert W. Male nipple abrasion protector
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
EP0826819B1 (de) * 1996-08-30 2002-11-20 Voith Paper Fiber Systems GmbH & Co. KG Vorrichtung zum Entwässern einer Faserstoffsuspension
US6168779B1 (en) * 1997-09-16 2001-01-02 The Regents Of The University Of California Methods and kits for identifying ductal orifices
US6221622B1 (en) * 1998-04-28 2001-04-24 The Regents Of The University Of California Method and kit for obtaining fluids and cellular material from breast ducts
US6096943A (en) * 1998-01-09 2000-08-01 Maiwald; Diane C Skin wound protector
US6143945A (en) * 1998-04-06 2000-11-07 Augustine Medical, Inc. Bandage for autolytic wound debridement
CA2253093A1 (en) * 1998-11-06 2000-05-06 Jiri J. Krepinsky Screening test for early detection of colorectal cancer
US6642009B2 (en) * 1999-05-17 2003-11-04 Cytyc Health Corporation Isolated ductal fluid sample
WO2001053450A1 (en) * 2000-01-21 2001-07-26 Thomas Jefferson University Nipple aspirate fluid specific microarrays
DE60140204D1 (de) * 2000-11-13 2009-11-26 Ensisheim Partners Llc Vorrichtung zum auffangen, behandeln und aufarbeiten von brustflüssigkeitsproben zur untersuchung von brusterkrankungen, einschliesslich krebs
US20020117169A1 (en) * 2001-02-27 2002-08-29 Kurz Daniel R. Cover and applicator for a portion of a mammalian body
WO2004034059A1 (en) 2002-10-11 2004-04-22 Sentina Biotechnology Incorporated Methods for detection of breast cancer
JP4055789B2 (ja) * 2005-05-20 2008-03-05 トヨタ自動車株式会社 バンパ構造
US20100256464A1 (en) 2007-05-14 2010-10-07 Dr. Susan Love Research Foundation Device for determining risk of developing breast cancer and method thereof

Also Published As

Publication number Publication date
AU2003278005A1 (en) 2004-05-04
JP2006502390A (ja) 2006-01-19
US20080096283A1 (en) 2008-04-24
DE60320821D1 (de) 2008-06-19
US20060246415A1 (en) 2006-11-02
EP1554584A1 (de) 2005-07-20
US7879614B2 (en) 2011-02-01
US20110124110A1 (en) 2011-05-26
US20120214245A1 (en) 2012-08-23
EP1554584B1 (de) 2008-05-07
CA2501330A1 (en) 2004-04-22
US8133737B2 (en) 2012-03-13
WO2004034059A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
DE60326567D1 (de) Diagnose von hepatozellulärem karzinom
NO339224B1 (no) Bedrede immunprøvemetoder
EP1996940A4 (de) Nachweis von krebs anhand von erhöhten bcl-2-konzentrationen
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
DE602004022943D1 (de) Verfahren zum nachweis von analyten auf grundlage von evaneszenzbelichtung und auf streuung beruhender nachweis von nanopartikelsondenkomplexen
PL1776587T3 (pl) Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem
ATE540319T1 (de) Verfahren für die bestimmung von fk506
WO2010011357A3 (en) Detection of prostate cancer using psa glycosylation patterns
ATE458831T1 (de) Verfahren zum nachweis von lungenneoplasmen in fäkalen proben
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE602004015626D1 (de) Bei brustkrebs
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
DE60321356D1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE523773T1 (de) Verfahren und installation zur bestimmung der rheologischen eigenschaften eines fluids sowie entsprechendes identifizierungsverfahren
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
DE60320821D1 (de)
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
WO2020102808A3 (en) Oral wash for oral fluid collection and analysis and methods of use thereof
EP2029745A4 (de) Diagnoseverfahren und -marker
DE602005018413D1 (de) Verfahren zur Zählung und Identifikation von Mikroorganismen
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties